CPT1, which catalyzes the acyl group transfer of long-chain fatty acyl-CoA to carnitine, is overexpressed in several tumor types, and has recently been implicated to play a critical role in cancer proliferation and resistance to treatment [34]. This evidence concerns the gene CPT2 and cancer.